Lymphoma

Showing NaN - NaN of 158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma Trial in United States (Bortezomib, Romidepsin)

Completed
  • Leukemia
  • Lymphoma
  • Chicago, Illinois
  • +4 more
Apr 19, 2018

Lymphoma Trial in Worldwide (Inotuzumab Ozogamicin (CMC-544))

Completed
  • Lymphoma
  • Inotuzumab Ozogamicin (CMC-544)
  • Birmingham, Alabama
  • +41 more
Oct 27, 2017

Lymphoma Trial in Worldwide (PCI-32765 (Ibrutinib))

Completed
  • Lymphoma
  • PCI-32765 (Ibrutinib)
  • Los Angeles, California
  • +53 more
Jul 14, 2017

Lymphoma Trial in United States (Rituximab, Cytarabine, Dexamethasone)

Terminated
  • Lymphoma
  • Rituximab
  • +6 more
  • Stanford, California
  • +67 more
May 23, 2017

Lymphoma Trial in United States (rituximab, lenalidomide)

Completed
  • Lymphoma
  • La Jolla, California
  • +78 more
Feb 6, 2017

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in United States (cyclosporine ophthalmic emulsion, )

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • cyclosporine ophthalmic emulsion
  • placebo
  • Palo Alto, California
  • +4 more
Jan 24, 2017

Lymphoma Trial in United States (doxorubicin HCl, vinblastine, standard subtotal nodal irradiation)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • +2 more
  • La Jolla, California
  • +21 more
Feb 16, 2017

Lymphoma Trial in United States (biological, drug, radiation)

Completed
  • Lymphoma
  • rituximab
  • +5 more
  • Mobile, Alabama
  • +91 more
Jan 12, 2017

Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)

Completed
  • Cachexia
  • +3 more
  • Juven
  • Non-Juven Supplement
  • Birmingham, Alabama
  • +249 more
Dec 6, 2016

Lymphoma Trial in United States (fostamatinib)

Completed
  • Lymphoma
  • Los Angeles, California
  • +10 more
Aug 9, 2016

Leukemia, Lymphoma Trial in United States (filgrastim, rituximab, cyclophosphamide)

Completed
  • Leukemia
  • Lymphoma
  • filgrastim
  • +12 more
  • San Diego, California
  • +30 more
Jul 1, 2016

GVHD, Lymphoma Trial in United States (carmustine, melphalan, etoposide)

Completed
  • Graft Versus Host Disease
  • Lymphoma
  • Birmingham, Alabama
  • +47 more
Jul 15, 2016

Lymphoma Trial in Puerto Rico, United States (filgrastim, rituximab, cyclophosphamide)

Completed
  • Lymphoma
  • filgrastim
  • +6 more
  • Anniston, Alabama
  • +80 more
Jul 15, 2016

Lymphoma Trial in Puerto Rico, United States (biological, drug, procedure)

Completed
  • Lymphoma
  • filgrastim
  • +11 more
  • Anniston, Alabama
  • +80 more
Jul 15, 2016

Lymphoma Trial in Puerto Rico, United States (doxorubicin HCl, topotecan HCl)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • topotecan hydrochloride
  • Anniston, Alabama
  • +75 more
Jul 12, 2016

Lymphoma Trial in Puerto Rico, United States (gemcitabine HCl, pegylated liposomal doxorubicin HCl, vinorelbine tartrate)

Completed
  • Lymphoma
  • gemcitabine hydrochloride
  • +2 more
  • Anniston, Alabama
  • +75 more
Jul 12, 2016

Lymphoma Trial in United States (filgrastim, cyclophosphamide, doxorubicin HCl)

Completed
  • Lymphoma
  • filgrastim
  • +5 more
  • Birmingham, Alabama
  • +46 more
Jul 12, 2016

Lymphoma Trial in United States (galiximab, rituximab)

Completed
  • Lymphoma
  • galiximab
  • rituximab
  • Washington, District of Columbia
  • +67 more
Jul 1, 2016

Lymphoma Trial in United States (galiximab)

Completed
  • Lymphoma
  • galiximab
  • Lewes, Delaware
  • +55 more
Jul 1, 2016

Patients With Aggressive Non-Hodgkin's Lymphoma

Completed
  • Lymphoma
  • comparative genomic hybridization
  • +3 more
  • Anniston, Alabama
  • +68 more
Jul 1, 2016

Lymphoma Trial in United States (filgrastim, rituximab, cytarabine)

Completed
  • Lymphoma
  • filgrastim
  • +6 more
  • San Francisco, California
  • +29 more
Jul 1, 2016

Lymphoma Trial in United States (epratuzumab, rituximab)

Completed
  • Lymphoma
  • epratuzumab
  • rituximab
  • San Diego, California
  • +42 more
Jul 1, 2016